Literature DB >> 1457632

Human babesiosis in New York State: an epidemiological description of 136 cases.

S C Meldrum1, G S Birkhead, D J White, J L Benach, D L Morse.   

Abstract

Epidemiological data on 136 cases of human babesiosis reported from laboratories and clinicians in the state of New York from 1982 to 1991 were reviewed. All but two patients, who had traveled to Nantucket Island in Massachusetts, acquired disease in Suffolk County, Long Island. The highest average age-group-specific annual incidence rates occurred among men > or = 80 years of age (7.72 per 100,000) and among women 70-79 years of age (3.61 per 100,000). Seven patients (5%) had previously undergone splenectomy, and 31 (23%) had evidence of concurrent Lyme disease. One hundred three patients (76%) were hospitalized, and seven (5%) died. Although the geographic distribution of this disease has remained constant, the recent introduction of babesiosis in mainland Connecticut and the spread of Lyme disease in New York suggest that the geographic distribution of babesiosis could also spread in New York.

Entities:  

Mesh:

Year:  1992        PMID: 1457632     DOI: 10.1093/clind/15.6.1019

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

Review 1.  Clinical manifestations of tick-borne infections in children.

Authors:  K A Bryant; G S Marshall
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  First case of (imported) babesiosis diagnosed in Canada.

Authors:  D Kunimoto; K Krause; D Morrison
Journal:  Can J Infect Dis       Date:  1998-11

Review 4.  Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.

Authors:  Maria A Diuk-Wasser; Edouard Vannier; Peter J Krause
Journal:  Trends Parasitol       Date:  2015-11-21

5.  Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota.

Authors:  P D Mitchell; K D Reed; J M Hofkes
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

Authors:  Neeharik Mareedu; Anna M Schotthoefer; Jason Tompkins; Matthew C Hall; Thomas R Fritsche; Holly M Frost
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

7.  A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse.

Authors:  Jacob E Lemieux; Alice D Tran; Lisa Freimark; Stephen F Schaffner; Heidi Goethert; Kristian G Andersen; Suzane Bazner; Amy Li; Graham McGrath; Lynne Sloan; Edouard Vannier; Dan Milner; Bobbi Pritt; Eric Rosenberg; Sam Telford; Jeffrey A Bailey; Pardis C Sabeti
Journal:  Nat Microbiol       Date:  2016-06-13       Impact factor: 17.745

8.  Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis.

Authors:  P J Krause; R Ryan; S Telford; D Persing; A Spielman
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Update on babesiosis.

Authors:  Edouard Vannier; Peter J Krause
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27

10.  Transfusion-associated babesiosis after heart transplant.

Authors:  Joseph Z Lux; Don Weiss; Jeanne V Linden; Debra Kessler; Barbara L Herwaldt; Susan J Wong; Jan Keithly; Phyllis Della-Latta; Brian E Scully
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.